Skip to main content
ResMed Inc. (ASX:RMD)
Australia flag Australia · Delayed Price · Currency is AUD
33.61
+0.57 (1.73%)
Apr 17, 2025, 4:10 PM AEST

ResMed Revenue

ResMed had revenue of $1.28B USD in the quarter ending December 31, 2024, with 10.26% growth. This brings the company's revenue in the last twelve months to $4.93B, up 9.38% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.

Revenue (ttm)
$4.93B
Revenue Growth
+9.38%
P/S Ratio
6.14
Revenue / Employee
$493.66K
Employees
9,980
Market Cap
48.92B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Mesoblast 9.16M
Revenue Rankings

ResMed News

More News